Table 2.
Hair Sample No. | Duration of PrEP (Weeks) | TFV Concentrationb (ng/mg Hair) | FTC Concentration (ng/mg Hair) |
---|---|---|---|
1 | 32 | 0.026 | 0.582 |
2 | 10 | 0.026 | 0.477 |
3 | 57 | 0.014 | 0.121 |
4 | 25 | 0.050 | 0.619 |
5 | NA | BLQ | BLQ |
6 | 142 | 0.027 | 0.265 |
7 | 11 | 0.037 | 0.705 |
8 | 28 | 0.040 | 1.167 |
9 | 11 | 0.009 | 0.213 |
10 | 11 | 0.031 | 0.761 |
11 | 59 | 0.028 | 0.537 |
12 | 156 | 0.005 | 0.040 |
13 | 11 | 0.027 | 0.092 |
14 | 47 | 0.030 | 0.093 |
15 | 48 | 0.020 | 0.194 |
Abbreviations: BLQ, below lower limit of quantification; FTC, emtricitabine; NA, not available; PrEP, pre-exposure prophylaxis; TFV, tenofovir.
aHair samples were analyzed by high-performance liquid chromatography-tandem mass spectrometry.
bOn average, a TFV value of 0.038 ng/mg hair is consistent with dosing 7 days per week, and 0.023 ng/mg hair is consistent with dosing 4 days per week [35]. In our small subset, 73% (11 of 15) had TFV values indicating at least 4 days per week adherence to PrEP.